For TRT & Hormone Optimization Programs

You normalized their hormones. The mirror didn’t get the memo.

Testosterone optimization is precision medicine for the bloodstream. Body recomposition is precision medicine for what the bloodstream can’t reach. FunSculpting is the clinical complement — a single-visit close for the stubborn 15% your TRT protocol doesn’t move, delivered to patients who already trust you with their hormones.

~65%
Of TRT patients convert to the regenerative biologic add-on — the highest rate of any specialty
$7K
Average combined case revenue — contouring plus biologics add-on for TRT patients
1x
Monthly TRT visit cadence — the perfect schedule to introduce body recomposition
The TRT Patient Timeline

Testosterone does most of the work. Then it plateaus.

Every TRT practitioner sees the same arc: quick wins in months one through three, body composition gains through months four through six, and then a plateau around month seven that hormones alone can’t push past. That plateau is where your patient starts asking different questions — and where most of them stop getting satisfying answers.

The predictable 12-month arc of optimization

Composite pattern observed across TRT practices. Individual response curves vary.
FunSculpting enters PLATEAU ZONE Mo 1 Mo 3 Mo 6 Mo 7 Mo 9 Mo 12 High Baseline PATIENT SATISFACTION
Months 1–3
The subjective wins
Energy, mood, libido, sleep. Patient feels transformed. Compliance is high. Your clinic earns trust.
Months 3–6
The visible wins
Lean mass increases. General adiposity drops. Scale moves. Body starts to match how they feel.
Months 6–9
The plateau
Labs look great. Body comp stalls. Stubborn fat pockets persist. Joint and recovery issues surface. Patient starts asking what’s next.
Months 9+
Maintenance & optimization
This is where FunSculpting lives. Complete the transformation. Regenerative support for the joint and recovery complaints. Patient stays invested — with you.

Your patient will find an answer to the plateau somewhere. The question is whether that answer comes from you, or from a medspa down the street that doesn’t know their labs, their protocol, or their history.

The Clinical Complement

What testosterone can’t touch. What FunSculpting does.

Testosterone moves lean mass and reduces general adiposity. It doesn’t selectively remove visceral fat pockets, doesn’t rebuild tissue in joint capsules taking the brunt of newly-active training, and doesn’t address the regenerative deficits that emerge when an optimized patient asks more of their body. FunSculpting addresses both vectors in a single system.

I.

Remove what hormones can’t move

Staff-administered 3D harmonic contouring targets the plateau zones testosterone leaves behind — flanks, submental fullness, chest-wall adiposity, stubborn abdominal pockets. Same-day visible result. No multi-session protocol that fights your monthly visit cadence, no 6-week metabolic wait, no return visits to close the loop.

Revenue per case $3,500–$6,500
II.

Regenerate what optimization demands

Harvested adipose ships same-day to L2Bio for stem cell processing. Returned biologics support joint capsule restoration, recovery capacity, and the musculoskeletal maintenance an optimized patient is actively loading. This is the add-on your TRT patients will ask for — orthopedic, longevity, and sexual wellness applications all fit.

Revenue per case $4,500–$8,000
The Revenue Model

TRT patients run lower volume. They run higher margin.

A weight-loss clinic may convert more FunSculpting patients per month. A TRT clinic converts fewer — but each case comes bundled at the top end of the case mix. Higher add-on conversion, higher per-case revenue, higher patient lifetime value. The math favors the quality premium.

Projected monthly net revenue
$40,500
Net of $4,400 monthly lease & per-case consumables at 7 patients/month with 65% stem cell conversion.
Adjust for your practice
TRT patients converting per month 7 / mo
Stem cell add-on rate 65%
Annual net $486,000
Open the full calculator →
Clinical Workflow

Fits the monthly visit cadence. Doesn’t fight your schedule.

TRT practices already operate on a monthly cadence — labs, dose adjustments, refills. FunSculpting slots into that cadence cleanly: the contouring conversation happens at a routine visit, the session itself is scheduled adjacent to the next month’s injection, and the regenerative injection can be performed at the visit after that. Three touchpoints across three months, fully integrated.

Step I.

Plateau conversation

Patient plateaus around month 7. Staff introduces the recomposition consult at the routine monthly visit. TRT patients convert at high rates — they already believe in clinical optimization.

During Monthly Visit
Step II.

Contouring session

Your MD, DO, NP, or PA performs the 60–90 minute FunSculpting session. Scheduled adjacent to the following month’s TRT visit so the patient makes one trip, not two.

Staff-Administered
Step III.

Harvest & process

Harvested adipose packaged on-site, shipped same-day to L2Bio. Stem cell processing completes in hours. Biologics return overnight — ready for the next scheduled visit.

Lab Partner Handles
Step IV.

Regenerative injection

Physician performs the biologic injection at the patient’s next monthly visit — typically <15 minutes. Injected into joint, musculoskeletal, or other regenerative target per the consult plan.

~15 Min Physician Time
Provider Evidence

What happens when an optimization practice adds this.

We covered the lease in the first month. By month three we had a full schedule and our staff was running the whole thing. Our patients convert themselves — they already know they need it, and they trust us to do it right.

Dr. Marcus T.
Functional Medicine & Wellness — Phoenix, AZ
Before You Book

The questions hormone clinic owners ask on the first call.

No meaningful pharmacological interaction. The 3D harmonic contouring mechanism is mechanical, not chemical. It operates on adipose tissue directly and does not affect hormone metabolism, receptor binding, or exogenous testosterone clearance. Patients continue their TRT protocol unchanged. The regenerative biologic injection uses the patient’s own autologous tissue and similarly does not interact with testosterone pharmacokinetics.
Most practices find the conversation lands best at the month-six to month-nine plateau, when the patient has seen the gains testosterone can deliver and is starting to ask “what’s next?” on their own. Introducing it earlier can feel premature; introducing it later can feel like you’re catching up to their frustration. On the demo we’ll review timing templates for different protocol types (injection, cream, pellet) and different patient populations.
Female patients on BHRT or low-dose testosterone protocols are often ideal candidates for the full service line — contouring for stubborn post-perimenopause body composition changes, biologic injections for joint and facial regenerative applications. Conversion rates in mixed-sex hormone practices are often higher than male-only TRT practices, specifically because female patients tend to engage with aesthetic and regenerative applications at higher rates.
Body recomposition and regenerative therapy are separate service lines with their own consent forms, documentation standards, and billing. Your hormone prescribing continues to operate under its existing coverage and DEA considerations. On the demo we’ll walk through the documentation protocol your malpractice carrier will expect — most practices find their carrier’s existing aesthetic-procedure rider covers the new service line with a minor endorsement.
Peptide patients are a natural overlap. Patients already self-selecting into peptide protocols are demonstrating interest in precision regenerative interventions — the mental leap to adipose-derived biologics is shorter for them than for a cold patient. Peptide and biologic protocols can run concurrently; they’re mechanistically distinct and clinically complementary. Many of our strongest TRT-clinic partners are also running peptide programs.
Sixteen CME credits of training included with the system, delivered on-site or virtually. Your MA, NP, or nurse runs the contouring step. The physician handles the regenerative injection — a procedure skill most TRT-prescribing clinicians already possess or can acquire quickly. Most practices see first patients within 21 days of system delivery.
The opposite, in most cases. FunSculpting becomes a retention mechanism — a patient who is about to plateau and potentially churn finds a new reason to stay. Average patient lifetime value increases because the TRT revenue continues and the recomposition revenue is net-new on top of it. No practice we work with has reported competing demand between the two service lines.

Your patients are already optimizing. Give them the next step.

Book a 30-minute demo — we’ll review your patient volume, your typical plateau timing, and the exact revenue mix for a hormone-optimization practice in your state.

FDA-cleared system 24-hour financing decisions 14 CME credits included 500+ active clinics